Home Bellerophon Therapeutics Announces Management and Board Additions
 

Keywords :   


Bellerophon Therapeutics Announces Management and Board Additions

2015-07-02 00:40:09| Biotech - Topix.net

Bellerophon Therapeutics, Inc. , a clinical-stage biotherapeutics company, today announced the appointments of Amit Agrawal as Chief Operating Officer, effective July 8, 2015, and Naseem Amin, M.D. as an Independent Director of the Company, effective June 29, 2015. Mr. Agrawal joins Bellerophon from Amgen, Inc., where, since 2012, he served as Director of Strategy and Corporate Development.

Tags: board management additions announces

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11topps now psa10
27.11 THE ORAL CIGARETTES SUCK MY WORLD
27.11 E
27.113DS .SD()
27.11181
27.11YAMAHA KUSHITANI LL
27.11tsnomi.com
27.11
More »